Noga Baumatz, the Israeli toddler whose family had launched a campaign to develop a gene therapy to treat her rare disease, has died at the age of 2, her family announced on Saturday.
“Yesterday evening, Noga’s amazing soul left her body. After a week-long battle in intensive care she decided it was time to pass on,” they said in a statement.
“We are broken and stunned by the death of our little warrior and wish to thank all of you, for walking with us through this hard time and offering your support.”
Baumatz was one of 20-30 people on earth to be diagnosed with Hoyeraal-Hreidarsson syndrome, an ultra-rare and fatal immunodeficiency disorder, which is characterized by bone marrow failure and a predisposition to cancer.
Noga Baumatz (Courtesy)
The Baumatz family — along with a geneticist friend, Dr. Noam Diamant — had been raising money for a treatment, and had opened a lab in Rehovot aimed at producing a gene therapy tailor-made for the toddler, to rectify the mutation of the RTEL1 gene, which preserves the length of the chromosome-protecting telemores.
Get The Times of Israel's Daily Edition
by email and never miss our top stories
By signing up, you agree to the
terms
It was a process they had hoped would take a year.
Baumatz is survived by her parents and two sisters.
She will be buried on Sunday in Karmei Yosef in central Israel.
אתמול בערב הנשמה הענקית של נגה עזבה את הגוף שלה.אחרי שבוע של מלחמה בטיפול נמרץ, היא החליטה להמשיך הלאה. אנחנו שבורים…
Posted by Save Noga להציל את נגה on Saturday, January 12, 2019
Bridging the US-Israel divide
While the heart of The Times of Israel’s work takes place in Israel, so many of Jerusalem’s actions are influenced by those in Washington’s halls of power.
As ToI’s US bureau chief, I work to gain access to decision-makers in the United States government so our readers can understand the US-Israel relationship beyond the platitudes evident in public statements.
I'm proud of our ability to inform without sensationalizing, our dedication to be fast while ensuring accuracy, and our determination to present Israel's entire, complex story.
Your support through The Times of Israel Community helps us continue to keep readers around the world properly informed about the critical Israel-US relationship. Do you appreciate our news coverage? If so, please join the ToI Community today.
- Jacob Magid, The Times of Israel's US bureau chief
Yes, I'll join
Yes, I'll join
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel eleven years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this